Creatine Monohydrate
Dietary SupplementPowder, 0.1 g per day, 12 months
Other names: Rivalus
NCT Number: NCT01057680
As we age, we experience a reduction in muscle and bone which inevitably decreases strength and the ability to perform tasks of daily living such as gardening, carrying groceries, and climbing stairs. Health costs associated with aging muscle and bone loss are in the billions of dollars. With the projected increase in life expectancy, the incidence of muscle and bone loss will rise and further drain the healthcare system, with greater need for hospitalization, treatment, and rehabilitation. Without effective strategies to counteract aging muscle and bone loss, we may face a healthcare crisis in the future. Creatine, a compound found in red meat and seafood, increases creatine phosphate stores in muscle, providing increased energy during high-intensity exercise. Short-term (i.e. 3-4 months) resistance-exercise and supplementation with creatine, have been shown to have a favorable effect on properties of aging muscle and bone. However, the longer-term (i.e. 1 year) effects of these interventions are unknown. Therefore, the purpose of this innovative research is to determine the longer-term effects of resistance-exercise and creatine supplementation (0.1g•kg-1) in older adults. The primary dependent variables to be assessed will include muscle hypertrophy, bone mineral and bone geometry, strength, and urinary and blood indicators of liver and kidney function. This innovative, multidisciplinary research will help contribute to the successful pursuit of prolonged independent living by improving aging musculoskeletal health for older Saskatchewan adults. Saskatchewan provides a relevant setting for this research, given the higher percentage of older adults (15%), compared to the national average (12%).
We hypothesize that creatine supplementation will increase muscle mass, strength, and bone mineral density more than placebo.
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Phase 3
Faculty of Kinesiology and Health Sciences, Regina, Saskatchewan, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Powder, 0.1 g per day, 12 months
Other names: Rivalus
powder, 0.1 g/day, 12 months
Time frame: Baseline and 12 months
Time frame: Baseline and 12 months
Time frame: baseline and 12 months
Time frame: baseline and 12 months
Time frame: baseline and 12 months
Time frame: baseline and 12 months
Time frame: Baseline and 12 months
Time frame: baseline and 12 months
Time frame: baseline, 4 months, 8 months, 12 months
Time frame: baseline, 4 months, 8 months, 12 months
Time frame: baseline, 4 months, 8 months, 12 months
University of Saskatchewan
Other
Potential of Resistance-Exercise and Creatine Supplementation on Aging Musculoskeletal Health
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03344718
Atrophy, Avitaminosis
Tainan, Taiwan
View Trial DetailsNCT06287502
Atrophy, Bone Diseases
Kowloon, Hong Kong
View Trial DetailsNCT05809466
Atrophy, Bone Diseases
Wageningen, Gelderland, Netherlands
View Trial DetailsNCT06900387
Atrophy, Bone Diseases
Pune, Maharashtra, India
View Trial Details